Novo Nordisk upgrades 2024 guidance
Pharmaceutical firm Novo Nordisk has released its financial results for the first three months of 2024, and has upgraded its guidance for the whole year.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Novo Holdings to invest USD 200m in quantum technologies
For subscribers